The GSK share price is 14% off its 52-week high. Time to consider buying?

The GSK share price has taken a tumble since peaking back in May. This Fool thinks now could be the time to take a closer look at the stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At £15.59, GSK’s (LSE: GSK) share price is 14% lower than the 52-week high of £18.23 it hit back in May. I reckon now could be a good time to take a closer look at the FTSE 100 pharmaceutical giant.

It has been a volatile year for the stock. But as a long-term investor, if I sense a strong buying opportunity, I’m content with riding out some short-term ups and downs. With that, let’s dig a little deeper into GSK.

Created with Highcharts 11.4.3GSK PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

Short-term challenges

There’s one main reason I see that explains why its share price has fallen. It’s linked to potential litigation surrounding Zantac, a heartburn drug that was taken off shelves in 2019 after being linked to causing cancer.

Should you invest £1,000 in Diageo right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Diageo made the list?

See the 6 stocks

Earlier this year, a judge in Delaware ruled in favour of around 72,000 lawsuits related to Zantac and its link to cancer to go forward.

This came as a shock decision. When it was revealed, it wiped almost £7bn off GSK’s value in just one day. Its share price has failed to recover since.

GSK now faces the potential of thousands of costly court cases. That clearly has investors worried. Analysts at Citi have said it could cost the firm up to £3bn in settlement fees.

Long-term growth

But looking past that, what could drive long-term growth for the business? Well, I see plenty of encouraging factors.

Its Q2 update highlighted its growing R&D pipeline. The business has now secured approvals or filings for 10 “major opportunities”. It also reported “positive data” from seven phase III trials.

In its results, the business upgraded its 2024 guidance. Sales growth should now come in between 7-9%. Core operating profit growth should sit between 11-13%.

Attractive value

Looking at its price-to-earnings (P/E) ratio, the stock looks like good value for money. It trades on a P/E of 16. As the chart below highlights, that’s significantly cheaper than industry peers such as AstraZeneca, which trades on a P/E of 38.2.


Created with TradingView

To go with that, the stock has a healthy dividend yield of 3.8%. Not only is that higher than the FTSE 100 average (3.6%), but, as seen below, it’s also higher than AstraZeneca’s 1.8% yield.


Created with TradingView

My move

With the stock trading below its 52-week high, I think now could be a smart time for investors to take a closer look at GSK and consider buying some shares.

Despite the potential challenges it could face in the months ahead, I think there’s a lot to like about the business.

Legal complications are always a threat when investing in pharma stocks. And no doubt further negative updates relating to Zantac could send its share price down again.

However, it’s a stock with a solid valuation. Plus, as it carries on growing its pipeline, I think the business is well-positioned to post strong growth in the coming years. I’ll be delving deeper into the FTSE 100 constituent in the weeks ahead.

Should you invest £1,000 in Diageo right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Diageo made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Charlie Keough has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca Plc and GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our best passive income stock ideas

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

More on Investing Articles

artificial intelligence investing algorithms
Investing Articles

Up 272% in just a year, is Palantir stock just getting started?

This writer recognises that Palantir has grown its business very well -- but does the stock price offer him an…

Read more »

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

Up 50%? The Aston Martin share price forecast is mind-blowing! 

If analysts are right, the Aston Aston Martin share price could absolutely rocket in the year ahead. Harvey Jones says…

Read more »

Investing Articles

As the S&P 500 drops, here are 2 Stocks and Shares ISA holdings I’m watching

Our writer has different views on how President Trump's tariffs might affect these two US holdings in his Stocks and…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

£10,000 invested in Tesla stock at Christmas is now worth…

Tesla stock has been one of best-performing investments of the past decade. But things haven't gone to plan for investors…

Read more »

Investing Articles

Up 279% in 5 years, could Meta stock keep soaring?

Meta stock has more than tripled in five years. This writer sees lots to like about the business but also…

Read more »

Pink 3D image of the numbers '2025' growing in size
Investing Articles

25% total return in a year? Is now the perfect time to buy BP shares?

BP shares are on the front line of today's global economic and political uncertainty but analysts think they can still…

Read more »

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

With Cash ISA changes coming, could now be the time to consider buying shares?

Changes to the Cash ISA could lead to greater investment in the stock market. This could be a good thing…

Read more »

Investing Articles

These FTSE 100 dividend shares just got cheaper, thanks to President Trump!

Investors buying dividend shares can lock in bigger long-term yields when share prices take a tumble. These two just did…

Read more »